CU Anschutz Cancer Center

.@coschoolofmines senior David Boylan, who was recently diagnosed with leukemia, graduated in the halls of the oncology ward at our clinical partner @uchealth in a surprise ceremony put together by his care team: cbsn.ws/4wJmU2h

Glioblastoma is the most common and most aggressive malignant brain tumor in adults, with most frequently diagnosed at ages 45–70. For Brain Cancer Awareness Month, learn more about glioblastoma: bit.ly/49W4xNB

#ClinicalTrialsDay: CU Anschutz Cancer Center's Jennifer Diamond, MD, shares why patients consider clinical trials. Explore our latest clinical trials and more: bit.ly/4dUgrdf

To better understand your risk of cancer, it helps to know your family health history. Learn more from CU Anschutz Cancer Center experts: news.cuanschutz.edu/cancer-center/…

Watch McKenna Russen, a GI clinical research coordinator in the CU Anschutz Cancer Center's Cancer Clinical Trials Office (CCTO), share a day in her life. Learn more about the CCTO: medschool.cuanschutz.edu/colorado-cance…

CU Anschutz Cancer Center's Saketh Guntupalli, MD, was named the 2026 Champion of Hope Award winner at this year's Cancer League of Colorado's Hope Ball! The CU Anschutz Cancer Center is a proud sponsor of this event.

With @FightCRC, Andi Dwyer, MPH, and Swati G. Patel, MD, helped lead an initiative to ensure that Lynch syndrome is included in International Classification of Diseases (ICD-10) codes: fightcolorectalcancer.org/fight-crc-secu…

The Tumor-Host Interactions program, led by Diana Cittelly, PhD, explores how the body shapes cancer, advancing immunotherapies for better patient outcomes. Watch the full interview here: youtu.be/ttGsG6o7oX0?si…

You may have heard of CAR T-cell therapy, but now there's an effort by Siddhartha Mitra, PhD, and his team to develop CAR M. The goal? To re-engineer marcophages instead of T cells, to "eat" cancer cells: bit.ly/3RjG52h

Former NBA player Jason Collins has passed away after a battle with Stage 4 glioblastoma, a rare form of brain cancer. In this Q&A, CU Anschutz Cancer Center member Douglas Ney, MD, talks about glioblastoma and its rising prevalence in younger patients ⬇️ bit.ly/497RCIy

CU Anschutz Cancer Center's @TejasPatilMD, and Peter Fecci, MD, PhD, are joining forces to investigate a new way to treat leptomeningeal disease stemming from a form of lung cancer: news.cuanschutz.edu/cancer-center/…

Congrats to CU Anschutz Cancer Center's Curtis Henry, PhD, on being named the American Association of Immunologists (@ImmunologyAAI) Vanguard Award winner in recognition of his research achievement and exemplary career success: news.aai.org/2026/05/06/cur…

🎉EXCITED to have participated in and share our work on modelling TKI resistance in #RET #NSCLC using novel murine models. ⭐️This work was led by my brilliant colleagues Drs. Trista Hinz, Lynn Heasley & Rafe Nemenoff, @CUCancerCenter! 👇🏽SEE BELOW for details 🧵(1/9)

How does chemotherapy work, and what are some of its side effects? CU Anschutz Cancer Center member @JennyXiangMD answers these questions: news.cuanschutz.edu/cancer-center/…

#BrainCancerAwarenessMonth: Peter Fecci, MD, PhD, CU Anschutz Cancer Center member and chair of the Department of Neurosurgery (@CUNSGY), shares the origins of cancer in the brain and how different types are treated: bit.ly/4tTxhyF

#BrainTumor researchers Drs Hankinson & Mitra @HankMitraLab talk about their groundbreaking craniopharyngioma research for #BrainTumorAwarenessMonth #GoGrayInMay @ChildrensColo @CUCancerCenter

Some cancer drugs disrupt taste by changing the cells inside taste buds, CU Anschutz Cancer Center-led research shows: bit.ly/4d1gcNr

Cancer center members Joanna Arch, PhD, and Jean Kutner, MD, MSPH, created an intervention for advanced cancer patients to help them with anxiety, depression, and advance care planning: bit.ly/41OVKZI

Super excited that the @CUCancerCenter now has a webpage highlighting how we care for older adults with cancer! Personalized, multidisciplinary, and focused on what matters most to patients 💪 Check it out 👇 medschool.cuanschutz.edu/colorado-cance…

What a success! Tune in for a recap - and we're looking forward to seeing you next year!